Bengaluru (Karnataka) [India], July 20: Recognising her exceptional contributions to diagnostic radiology, medical research, and artificial intelligence in healthcare, Dr. Ohmini Krishnamurthy Rajendran, MBBS, MD (Radiodiagnosis), has been conferred with the Bharat Shreshtha Ratna Sanman 2026. The prestigious recognition celebrates her commitment to transforming modern medicine through innovation, precision imaging, and translational research.
A Radiologist at the Department of Radiodiagnosis, Kempegowda Institute of Medical Sciences & Research Centre (KIMS), Bengaluru, Dr. Rajendran has built a distinguished career at the intersection of clinical medicine and technological advancement. Alongside her academic role, she serves as a Consultant Radiologist at multiple healthcare institutions, contributing specialist expertise across a wide range of diagnostic imaging services.
Over the years, Dr. Rajendran has emerged as one of the leading voices advocating for the integration of artificial intelligence into radiology and precision oncology. Her research explores how advanced imaging technologies, radiomics, predictive analytics, explainable artificial intelligence (XAI), and precision medicine can improve diagnostic accuracy, support clinical decision-making, and enable more personalised treatment strategies for patients.
The Bharat Shreshtha Ratna Sanman 2026 recognises not only her scientific accomplishments but also her broader contribution to healthcare innovation. Her academic journey reflects an unwavering commitment to advancing evidence-based medicine through research that directly addresses real-world clinical challenges.
With more than six years of clinical experience, Dr. Rajendran has authored six academic books covering radiology, oncology, artificial intelligence, and healthcare innovation. She has also published sixteen international research papers and contributed extensively to scientific literature that continues to influence discussions on the future of medical imaging and precision healthcare.
Her work as an inventor further demonstrates her commitment to innovation. Holding eight published Indian Utility Patents and one U.S. Utility Patent, she has focused on developing intelligent healthcare solutions designed to strengthen diagnostic capabilities and improve patient outcomes. Her research has earned more than 500 citations and an H-index above 15, reflecting the growing impact of her contributions within the international scientific community.
Beyond research and clinical practice, Dr. Rajendran actively contributes to global academic advancement as an Editorial Board Member, international peer reviewer, keynote speaker, invited faculty member, and session chair at scientific conferences. Through these roles, she continues to promote interdisciplinary collaboration while encouraging the responsible adoption of emerging technologies in medicine.
Earlier in her career, her involvement in community medicine and public health initiatives reinforced her belief that meaningful healthcare extends beyond hospitals and laboratories. That perspective continues to shape her approach to research, ensuring that innovation remains closely aligned with improving patient care and public health outcomes.
Receiving the Bharat Shreshtha Ratna Sanman 2026 marks another significant milestone in Dr. Rajendran’s professional journey. The honour recognises a physician-scientist whose work exemplifies how clinical excellence and technological innovation can come together to redefine the future of healthcare.
Driven by a vision of predictive, personalised, and patient-centred medicine, Dr. Rajendran continues to contribute to the evolving landscape of radiology and medical science. As healthcare increasingly embraces artificial intelligence and precision medicine, her work stands as an example of how research, innovation, and compassionate clinical practice can collectively improve lives. The Bharat Shreshtha Ratna Sanman 2026 celebrates not only her achievements but also the lasting impact of her dedication to advancing smarter, safer, and more effective healthcare for future generations.
If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
